SANGAMO THERAPEUTICS, INC. Proceeds from Sale of Productive Assets
SANGAMO THERAPEUTICS, INC. (SGMOQ) reported Proceeds from Sale of Productive Assets of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Cash Flow › Investing Activities
us-gaap:ProceedsFromSaleOfProductiveAssets · last filed 2026-03-30
- SANGAMO THERAPEUTICS, INC. proceeds from sale of productive assets for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- SANGAMO THERAPEUTICS, INC. proceeds from sale of productive assets for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- SANGAMO THERAPEUTICS, INC. proceeds from sale of productive assets for the quarter ending 2024-12-31 was $1.48M.
- SANGAMO THERAPEUTICS, INC. proceeds from sale of productive assets for the quarter ending 2024-09-30 was $348.00K.
- SANGAMO THERAPEUTICS, INC. proceeds from sale of productive assets for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- SANGAMO THERAPEUTICS, INC. proceeds from sale of productive assets for fiscal 2024 was $1.95M.
| Period end | Proceeds from Sale of Productive Assets 3 month | Proceeds from Sale of Productive Assets 6 month | Proceeds from Sale of Productive Assets 9 month | Proceeds from Sale of Productive Assets 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $0.00 derived: sum of 2 quarters · filed 2026-03-30 | $0.00 10-K · filed 2026-03-30 | |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $0.00 10-Q · filed 2025-11-06 | ||
| 2025-06-30 | $0.00 10-Q · filed 2025-08-07 | |||
| 2024-12-31 | $1.48M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $1.82M derived: sum of 2 quarters · filed 2026-03-30 | $1.95M 10-K · filed 2026-03-30 | |
| 2024-09-30 | $348.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $475.00K 10-Q · filed 2025-11-06 | ||
| 2024-06-30 | $127.00K 10-Q · filed 2025-08-07 | |||
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $0.00 10-Q · filed 2024-11-12 | ||
| 2023-06-30 | $0.00 10-Q · filed 2024-08-06 |